WallStSmart
AGL

agilon health Inc

NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES

$59.61
+1.70% today

Updated 2026-06-05

Market cap
$1.54B
P/E ratio
P/S ratio
0.27x
EPS (TTM)
$-22.59
Dividend yield
52W range
$7 – $95
Volume
0.8M

agilon health Inc (AGL) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-103.86M$-53.20M$-148.16M$-130.81M$-156.20M$-57.78M$-105.76M
Capital expenditures$3.91M$2.35M$13.43M$32.66M$30.82M$13.25M$13.24M
Depreciation
Stock-based comp$5.22M$6.69M$292.39M$28.38M$69.33M$50.66M$49.12M
Free cash flow$-107.77M$-55.55M$-161.59M$-163.47M$-187.01M$-71.03M$-119.00M
Investing cash flow
Financing cash flow
Dividends paid$6.87M
Share repurchases
Debt repayment
Net change in cash$915.73M$-547.14M

Frequently asked questions

What is agilon health Inc's revenue?

agilon health Inc's trailing twelve-month revenue is $5.82B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is AGL?

In its most recent fiscal year, AGL ran a gross margin of -3.18%, an operating margin of -7.10%, and a net margin of -6.83%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does AGL generate?

AGL produced $-119.00M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is AGL's balance sheet healthy?

AGL holds $173.71M in cash and equivalents against $15.75M in long-term debt, on $126.73M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.